Stacy Alyse Malaker

Title: Innovations by Stacy Alyse Malaker

Introduction

Stacy Alyse Malaker is a prominent inventor based in Menlo Park, California. She has made significant contributions to the field of immunotherapy and diagnostics, holding 2 patents that reflect her innovative work. Her research focuses on developing target peptides that can enhance immune responses against diseases such as cancer.

Latest Patents

One of her latest patents is titled "Target peptides for immunotherapy and diagnostics." This patent presents a set of target peptides that are displayed by HLA A*0101, A*0201, A*0301, B*4402, B*2705, B*1402, and B*0702 on the surface of disease cells. These peptides are envisioned to serve multiple purposes, including stimulating an immune response to proliferative diseases like cancer, functioning as immunotherapeutics in adoptive T cell therapy or as vaccines, facilitating antibody recognition of tumor boundaries in surgical pathology samples, acting as biomarkers for early detection and diagnosis of diseases, and serving as targets in the generation of antibody-like molecules that recognize the target-peptide/MHC complex.

Career Highlights

Stacy has worked at esteemed institutions such as the University of Virginia and the University of Birmingham. Her work has been instrumental in advancing the understanding of immune responses and developing new therapeutic strategies.

Collaborations

Some of her notable coworkers include Donald F. Hunt and Jeffrey Shabanowitz, who have contributed to her research endeavors.

Conclusion

Stacy Alyse Malaker's innovative work in immunotherapy and diagnostics showcases her dedication to advancing medical science. Her patents and collaborations highlight her significant impact in the field, paving the way for future advancements in cancer treatment and diagnosis.